These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28615135)

  • 1. Combined therapy for epistaxis by hereditary hemorrhagic teleangiectasia: A 3-year follow up study on 45 patients.
    Papaspyrou G; Hecker D; Linxweiler M; Schick B; Al Kadah B
    J Craniomaxillofac Surg; 2017 Aug; 45(8):1179-1182. PubMed ID: 28615135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser-Assisted Control of Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Systematic Review.
    Abiri A; Goshtasbi K; Maducdoc M; Sahyouni R; Wang MB; Kuan EC
    Lasers Surg Med; 2020 Apr; 52(4):293-300. PubMed ID: 31441079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of temporary nasal occlusion (tNO) on epistaxis frequency in patients with hereditary hemorrhagic telangiectasia (HHT).
    Wirsching KEC; Haubner F; Kühnel TS
    Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1891-1896. PubMed ID: 28070641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.
    Mahoney EJ; Shapshay SM
    Am J Rhinol; 2006; 20(1):87-90. PubMed ID: 16539301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neodymium-YAG laser intranasal photocoagulation in hereditary hemorrhagic telangiectasia: an update report.
    Kluger PB; Shapshay SM; Hybels RL; Bohigian RK
    Laryngoscope; 1987 Dec; 97(12):1397-401. PubMed ID: 3683050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First experiences with an individual nasal olive in patients with hereditary haemorrhagic telangiectasia (HHT).
    Al Kadah B; Papaspyrou G; Schneider M; Schick B
    Eur Arch Otorhinolaryngol; 2015 Jan; 272(1):117-22. PubMed ID: 24854232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire.
    Karapantzos I; Tsimpiris N; Goulis DG; Van Hoecke H; Van Cauwenberge P; Danielides V
    Eur Arch Otorhinolaryngol; 2005 Oct; 262(10):830-3. PubMed ID: 15739086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nd:YAG laser therapy of recurrent epistaxis in hereditary hemorrhagic telangiectasia].
    Werner JA; Lippert BM; Geisthoff UW; Rudert H
    Laryngorhinootologie; 1997 Aug; 76(8):495-501. PubMed ID: 9376034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nd:YAG laser treatment of recurrent epistaxis in heredity hemorrhagic telangiectasia.
    Velegrakis GA; Prokopakis EP; Papadakis CE; Helidonis ES
    J Otolaryngol; 1997 Dec; 26(6):384-6. PubMed ID: 9438937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epistaxis in patients with hereditary hemorrhagic teleangiectasia].
    Jovancević L; Mitrović SM
    Med Pregl; 2006; 59(9-10):443-9. PubMed ID: 17345820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of epistaxis in patients with hereditary hemorrhagic telangiectasia.
    Siegel MB; Keane WM; Atkins JF; Rosen MR
    Otolaryngol Head Neck Surg; 1991 Nov; 105(5):675-9. PubMed ID: 1754250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of hereditary hemorrhagic telangiectasia by Nd-YAG laser photocoagulation.
    Shapshay SM; Oliver P
    Laryngoscope; 1984 Dec; 94(12 Pt 1):1554-6. PubMed ID: 6542166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sinonasal quality of life outcomes following laser treatment of epistaxis related to hereditary hemorrhagic telangiectasia.
    Kuan EC; Peng KA; Thompson CF; Suh JD; Wang MB
    Lasers Med Sci; 2017 Apr; 32(3):527-531. PubMed ID: 28116537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical strategy in hereditary hemorrhagic telangiectasia.
    Kühnel TS; Wagner BH; Schurr CP; Strutz J
    Am J Rhinol; 2005; 19(5):508-13. PubMed ID: 16270607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of Nd:YAG laser photocoagulation vs. liquid paraffin plus antiseptic cream in the treatment of recurrent epistaxis.
    Zhang J; Qiu R; Wei C
    Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3721-5. PubMed ID: 25595351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds.
    Pagella F; Matti E; Chu F; Pusateri A; Tinelli C; Olivieri C; Canzonieri C; Boeri L; Ornati F; Danesino C
    Acta Otolaryngol; 2013 Feb; 133(2):174-80. PubMed ID: 23066781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease) Management of epistaxis and oral hemorrhage by Nd-Yag laser].
    Galletta A; Amato G
    Minerva Stomatol; 1998 Jun; 47(6):283-6. PubMed ID: 9738363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of electrosurgical plasma coagulation and potassium-titanyl-phosphate laser photocoagulation for treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
    Luk L; Mace JC; Bhandarkar ND; Sautter NB
    Int Forum Allergy Rhinol; 2014 Aug; 4(8):640-5. PubMed ID: 24719397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Argon plasma coagulation and topically applied estriol. Long-term results in the treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa].
    Sadick H; Riedel F; Oulmi J; Hörmann K; Bergler WF
    HNO; 2003 Feb; 51(2):118-24. PubMed ID: 12589417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial comparing Nd:YAG laser photocoagulation and bipolar electrocautery in the management of epistaxis.
    Zhang J; Cao L; Wei C
    Lasers Med Sci; 2017 Sep; 32(7):1587-1593. PubMed ID: 28707034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.